Prolonged tumor-free survival, CTL and Th1 response against B16F10 melanoma were observed in mice treated with the widely known p-CMV-MART1 DNA vaccine delivered by different types of vehicles, such as liposomes or gold particles, functionalized by a mannose-mimicking shikimoyl group [79,80,81]. The gene discussed is MLANA; the disease is melanoma.